期刊文献+

血清人附睾蛋白4、糖链抗原125及卵巢恶性肿瘤风险算法在上皮性卵巢癌二元论分型中的应用价值 被引量:9

The application value of serum HE4,CA125 and ovarian malignant tumor risk algorithms in the dualistic classification of epithelial ovarian cancer
原文传递
导出
摘要 目的探讨血清HE4和CA125及ROMA在上皮性卵巢癌二元论分型中的价值。方法选择2016年1月-2018年6月温州医科大学第二附属医院因盆腔肿块收治而拟行手术的患者,其中上皮性卵巢癌(Epithelial ovarian cancer,EOC)患者112例(Ⅰ型63例,Ⅱ型49例),卵巢良性疾病(Benign ovarian disease,BOD)患者169例,另包括同期体检后各项指标正常对照(Normal control,NC)100例;采用电化学发光法检测血清HE4、CA125水平,并计算ROMA指数值,分析3个指标在上皮性卵巢癌中的应用价值。结果EOC组HE4、CA125及ROMA指数水平显著高于NC组和BOD组(P<0.01),而NC组和BOD组3个指标水平无差异(P>0.05);EOC患者随着FIGO病理分期增加,HE4、CA125水平和ROMA指数逐渐升高,并且EOC-II患者HE4、CA125水平和ROMA指数显著高于EOC-Ⅰ患者;ROMA指数诊断卵巢癌效率优于HE4和CA125,并且ROMA指数区分EOC-Ⅰ和EOC-Ⅱ特异性优于HE4和CA125,而HE4和CA125敏感性更高。结论HE4和CA125在诊断EOC中的敏感性优于ROMA指数,但是ROMA指数在诊断EOC和EOC分型中更有效,特异度更高。 Objective To investigate the values of serum HE4,CA125,and ROMA in the dualistic classification of epithelial ovarian cancer.Methods The patients who planned to undergo surgery for pelvic masses were selected from the Second Affiliated Hospital of Wenzhou Medical University from January 2016 to June 2018.Among them,112 patients were with epithelial ovarian cancer(EOC)(63 cases of type I,49 cases of type II),169 patients were the benign ovarian disease(BOD),and100 people for medical examination were included at the same time as the normal control(NC).HE4 and CA125 levels were detected by electrochemiluminescence.And then the ROMA index value were calculated and the application value of three indicators in epithelial ovarian cancer were analyzed.Results The levels of HE4,CA125,and ROMA in the EOC group were significantly higher than those in the NC and BOD groups,but there was no difference in the levels of the three indexes in the NC and BOD groups(P<0.01).With the increase of FIGO pathological stages in EOC patients,the levels of HE4,CA125 and ROMA index gradually increased,and the levels of HE4,CA125 and ROMA index in EOC-Ⅰpatients were significantly higher than those in EOC-Ⅰpatients;the specificity of CA125 and ROMA index is better than that of HE4 and CA125,and the sensitivity of HE4 and CA125 is higher.Conclusion The sensitivity of HE4 and CA125 in the diagnosis of EOC is better than that of ROMA index,but ROMA index is more effective and specific in the diagnosis of EOC and EOC classification.
作者 王桂业 陈琼 谢奇朋 WANG Gui-ye;CHEN Qiong;XIE Qi-peng(Laboratory Medicine,the Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325027,China)
出处 《中国卫生检验杂志》 CAS 2020年第2期132-135,140,共5页 Chinese Journal of Health Laboratory Technology
基金 国家自然科学基金(81601849) 温州市科技局项目(Y20160075)。
关键词 上皮性卵巢癌 人附睾蛋白4 糖链抗原125 卵巢恶性肿瘤风险算法 二元论分型 Epithelial ovarian cancer Human epididymis protein 4 CA125 Ovarian malignant tumor risk algorithm Dualistic classification
  • 相关文献

参考文献7

二级参考文献45

  • 1Jacobs I J, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics, 2004, 3 : 355- 366.
  • 2Bast RC Jr, Brewer M, Zou C, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res, 2007, 174:91-100.
  • 3Morgan RJ Jr, Alvarez RD, Armstrong DK, et al. Ovarian cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2006, 4:912-939.
  • 4Rustin GJ, Bast RC Jr, Kelloff GJ, et al. Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res, 2004, 10:3919-3926.
  • 5Hellstrom I, Raycraft J, Hayden-Ledbetter, et al. The HE4 (WFIXE) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003, 63 : 3695 -3700.
  • 6Havrilesky LJ, Whitehead CM, Rubatt JM, et al. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. Gynecol Oncol, 2008, 110 : 374-382.
  • 7Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol, 2008, 108:402-408.
  • 8Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2009, 112: 40-46.
  • 9Sun-Young Kong,Mi Han,Heon-Jong Yoo,Jong Hwang,Myong Lim,Sang-Soo Seo,Chong-Woo Yoo,Jae-Hoon Kim,Sang-Yoon Park,Sokbom Kang.Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer[J].Annals of Surgical Oncology.2012(5)
  • 10Jiheum Paek,San-Hui Lee,Ga-Won Yim,Maria Lee,Young-Jae Kim,Eun-Ji Nam,Sang-Wun Kim,Young-Tae Kim.Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer[J].European Journal of Obstetrics and Gynecology.2011(2)

共引文献126

同被引文献90

引证文献9

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部